Efficacy of doxorubicin as an induction agent for cats with lymphosarcoma

Australian Veterinary Journal

Volumn 77, Issue 7, 1999, Pages 442-444

  Peaston, A E ^a   Maddison, J E ^b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b NONE

Author keywords

Cat; Chemotherapy; Doxorubicin; Feline; Lymphosarcoma

Indexed keywords

FELIDAE; FELIS CATUS;

ANTINEOPLASTIC AGENT; DOXORUBICIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; AUSTRALIA; CAT; CAT DISEASE; CLINICAL TRIAL; FEMALE; LYMPHOSARCOMA; MALE; MULTICENTER STUDY; NEW ZEALAND; PROSPECTIVE STUDY; REMISSION; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; AUSTRALIA; CAT DISEASES; CATS; DOXORUBICIN; FEMALE; LYMPHOMA, DIFFUSE; MALE; NEW ZEALAND; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0033160696     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.1999.tb12087.x     Document Type: Article

References (16)

1. Court EA, Watson ADJ, Peaston AE. Retrospective study of 60 cases of feline lymphosarcoma. Aust Vet J 1997;75:424-427.
2. Mahony OM, Moore AS, Cotter SM et al. Alimentary lymphoma in cats: 28 cases (1988-1993). J Am Vet Med Assoc 1995;207:1593-1598.
3. Mooney SC, Hayes AA, MacEwen EG et al. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981). J Am Vet Med Assoc 1989;194:696-699.
4. Moore AM, Cotter SM, Frimberger AE et al. A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma. J Vet Intern Med 1996;10:372-375.
5. Carter RF, Harris CK, Withrow SJ et al. Chemotherapy of canine lymphoma with histopathological correlation: doxorubicin alone compared to COP as first treatment regimen. J Am Anim Hasp Assoc 1987;23:587-596.
6. Hahn KA, Richardson RC, Teclaw RF et al. Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma. J Vet Intern Med 1992;6:3-10.
7. Cotter SM. Treatment of lymphosarcoma and leukemia with cyclophosphamide, vincristine, and prednisone: II treatment of cats. J Am Anim Hasp Assoc 1983;19:166-172.
8. Canfield PJ. Clinical, morphological and immunological characterisation of feline lymphoproliferative disorders. Australian Companion Animal Health Foundation Annual Report, Sydney, 1996:1.
9. Shelton GH, Grant CK, Cotter SM et al. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). J Acq Immunodefic Syndr 1990;3:623-630.
10. Friend SCE, Birch CJ, Lording PM et al. Feline immunodeficiency virus: prevalence, disease associations and isolation. Aust Vet J 1990;67:237-243.
11. Robertson ID, Robinson WF, Alexander R et al. Feline immunodeficiency virus and feline leukaemia virus in cats. Aust Vet Pract 1990; 20:66-69.
12. Shaw SE, Robertson ID, Robinson WF et al. Feline immunodeficiency virus: disease associations. Aust Vet Pract 1990;20:194-198.
13. Malik R, Kendall K, Cridland J et al. Prevalences of feline leukaemia virus and feline immunodeficiency virus infections in Sydney. Aust Vet J 1997;75:323-327.
14. Vonderhaar MA. Comparison of doxorubicin and epirubicin in a clinical trial of dogs with multicentric malignant lymphoma. Vet Cancer Soc Newsl 1994;18:8-9.
15. Valerius KD, Ogilvie GK, Mallinckrodt CH et al. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995). J Am Vet Med Assoc 1997;210:512-516.
16. Maddison JE, Peaston AE, Church DB. Treatment of 42 cases of canine lymphosarcoma with combination chemotherapy: 1987-1993. Aust Vet Pract 1994;24:94-101.